Serina Therapeutics Inc (SER) — Strategic Asset Allocation Index
Serina Therapeutics Inc (SER) has a Strategic Asset Allocation Index of 56.0% as of September 2025. Strategic assets (PP&E of $892.00K plus long-term investments of $-) total $892.00K, measured against net assets of $1.59 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See SER net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Serina Therapeutics Inc Strategic Asset Allocation Index (2024–2024)
This chart shows how Serina Therapeutics Inc's Strategic Asset Allocation Index has evolved across 1 annual periods from 2024 to 2024. As of September 2025, the index stands at 56.0%, representing strategic assets of $892.00K against net assets of $1.59 Million USD. For live market cap and overall valuation, see Serina Therapeutics Inc stock valuation.
Annual Strategic Asset Allocation Index for Serina Therapeutics Inc (2024–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Serina Therapeutics Inc from 2024 to 2024, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is Serina Therapeutics Inc's book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 206.3% | $1.05 Million | $1.05 Million | $- | $508.00K | — |